The drug maker said the audit of its API manufacturing plant at Miryalaguda in Telangana, by the US FDA, has been completed.
from Healthcare/Biotech-Industry-Economic Times http://bit.ly/2Hyg0YX
via IFTTT
Home »
Healthcare/Biotech-Industry-Economic Times
» Dr Reddy's gets FDA nod for 'Tosymra' migraine nasal spray
0 comments:
Post a Comment